SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
CEPH Analysis & Videos »
CEPH: Bull or Bear?
FDA Calendar Updates: POZN, AZN, SNY, CEPH, APPY, CYTR
CEPH
|
|
|
-1.98%
in
157 days
<> Below is a summary of updates to the <font> BioMedReports.com FDA Calendar </font> , which includes a database of over 200 entries. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of <font> BioMedReports.com </font> , the FDA Calendar has expanded to include the following categories: pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), pending complete response letter (CRL) re-submissions to the FDA, and pending late-st...
|
FDA Calendar Update: Acusphere (OTC:ACUS), Cephalon (NASDAQ:CEPH)
CEPH
|
|
|
-3.03%
in
36 days
(closed on 06/30/09)
<> Below is a summary of updates to the <font> BioMedReports.com </font> database of over 200 entries included in the <font> FDA and Clinical Trial Calendars </font> . The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FDA sorted by their PDUFA decision deadline dates while the Clinical Trial Calendar encompasses pending clinical trial results (with a focus on late-stage, Phase 3 trials), pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), and pending re-submissions to the FDA fo...
|
FDA Calendar Updates: SNTS, CEPH, AZN, DNDN, GILD, NVO
CEPH
|
|
|
-14.16%
in
49 days
(closed on 05/25/09)
<> The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FDA sorted by their PDUFA deadline dates. The entries are updated on a daily basis as new information becomes available with a total of 112 entries through 4/6/09. The FDA Calendar includes the following information: company name, ticker...
|
Updated Clinical Trial and FDA Decision Calendars
CEPH
|
|
|
-1.19%
in
20 days
(closed on 04/06/09)
<> <> Updated Clinical Trial and FDA Calendars
Below is a summary of updates to the www.BioMedReports.co <wbr> </wbr> m database of 243 entries included in the FDA and Clinical Trial Calendars.
http://biomedreports <wbr> </wbr> .com/fda-calendar.ht <wbr> </wbr> ml
The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FDA sorted by their PDUFA deadline dates. The entries are updated on a daily basis as new information becomes available with a total of 104 entries through today. The FDA Calend...
|
A New Index of Health Product Innovators
CEPH
|
|
|
-11.30%
in
71 days
(closed on 03/17/09)
<> 
The accompanying table includes statistics and all 23 companies in the ETF Innovators [ETFI] Global Health Innovators Index of companies with market caps over $250M which received FDA approval in the past 12 months for an original new drug product or medical device.
The index includes companies which get approvals for drugs or biological agents classified as new chemical entities (i.e. excluding all new formulations of existing drugs, generic drugs, and label extensions for existing products). Also, companies whi...
|
ETFI Health Innovators Index: Does R&D Lead to Higher Stock Prices?
CEPH
|
|
|
+6.58%
in
53 days
(closed on 01/05/09)
<> 
<> The accompanying table includes statistics and the top five rated companies in the ETFI Global Health Innovators Index of companies with market caps over $100M which received FDA approval in the trailing 12-month period for either an original new drug or medical device product. The index includes companies which get approvals for drugs or biological agents classified as new chemical entities (i.e. excluding reformulations of existing drugs, generic drugs, and label extensions for existing produc...
|
Bullish on CEPH ...
CEPH
|
|
|
-27.71%
in
790 days
<> <> <> Stop $73. Above the 50-day. New green bar.
*My thoughts on media, analysts, and hype: Everybody's selling something. Media are selling eyeballs watching advertising. They like to generate riviting content like arguments, shouting matches, overblown headlines, and outrageous guests to keep you watching. Analysts are selling "tips" and excitement, to get you to trade. Their masters make money off your trades, whether up or down. Cramer says "Stop Trading" but he then gives you dozens of stocks you should buy buy buy or sell sell sell. Pimco sells bond funds, so Bill Gross gives y...
|
People Bullish on CEPH
People Bearish on CEPH
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
| StreetInsider.com on CEPH |
More Resources
|
About Cephalon Inc
- Answers.com
